New study aims to predict cognitive recovery in kids with brain tumors
NCT ID NCT02914067
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how brain tumors and their treatments affect thinking skills in children aged 4 to 18. Researchers will use brain scans and cognitive tests to find early signs of future cognitive problems. The goal is to better predict which children will recover and how to help them. No new treatments are being tested; the focus is on gathering information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2016
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Cohort 1 (30 patients will be enrolled to this cohort) Inclusion Criteria: * Between 4 and 18 years of age, inclusive * Newly diagnosed primary brain tumor of any location and any histology * Life expectancy of at least one year * Able to understand and willing to consent or assent to the research proposed, along with consent of legal guardian(s) if applicable Exclusion Criteria: * Presence of visual impairment to an extent that the patient is unable to complete the computer testing * Contraindication to MRI scan (i.e. due to cardiac pacemaker) * Programmable Shunt Cohort 2 (150 patients will enrolled to this cohort. This may include some or all of the patients enrolled to Cohort 1.) Inclusion Criteria: * Between 4 and 18 years of age, inclusive * Previous diagnosis of a posterior fossa brain tumor; patients who are either undergoing active treatment for posterior fossa tumor or who have completed treatment will be eligible for study enrollment * Life expectancy of at least one year * Able to understand and willing to consent assent to the research proposed, along with consent of legal guardian(s) if applicable Exclusion Criteria: * Presence of visual impairment to an extent that the patient is unable to complete the computer testing * Contraindication to MRI scan (i.e. due to cardiac pacemaker) Cohort 3 (20 patients will be enrolled to this cohort. This may include some or all of the patients enrolled to Cohort 1) Inclusion Criteria * Between 4 and 18 years of age, inclusive * Previous diagnosis of a posterior fossa brain tumor * Clinical diagnosis of post-operative posterior fossa syndrome * Inability to complete NIH Toolbox * Life expectancy of at least one year * Able to understand and willing to consent assent to the research proposed, along with consent of legal guardian(s) if applicable Exclusion Criteria * Contraindication to MRI scan (i.e. due to cardiac pacemaker) Cohort 4 (50 Patients will be enrolled to Cohort 4. This will include patients previously enrolled on Cohorts 1-3 above.) Inclusion Criteria * Between 12-30 years of age, inclusive * Diagnosis of a brain tumor \>3 years prior to study enrollment * Life expectancy of at least one year * Able to understand and willing to consent assent to the research proposed, along with consent of legal guardian(s) if applicable * Patient must be able to complete a 1 hour MRI scan without sedation Exclusion Criteria * Contraindiciation to MRI scan (i.e. due to cardian pacemaker) * Presence of dental braces or programmable shunt * Patient requires sedation for MRI scan
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Childhood brain tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.